SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2016-12-28
Tx date 2016-12-27 		$APO
Acasti Pharma Inc. 		Moretz, John Morris
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-6,950
-5,000 vol
$1.39 each 		50,000
Filed 2016-12-23
Tx date 2016-12-23 		$APO
Acasti Pharma Inc. 		Moretz, John Morris
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-6,750
-5,000 vol
$1.35 each 		55,000
Filed 2016-12-22
Tx date 2016-12-21 		$APO
Acasti Pharma Inc. 		Moretz, John Morris
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-23,764
-20,000 vol
$1.19 each 		60,000
Filed 2016-11-30
Tx date 2016-11-27 		$APO
Acasti Pharma Inc. 		O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-30
Tx date 2016-11-27 		$APO
Acasti Pharma Inc. 		O'Keefe, Linda Parinella
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-07
Tx date 2016-11-07 		$APO
Acasti Pharma Inc. 		Villeneuve, Étienne
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-07
Tx date 2016-11-07 		$APO
Acasti Pharma Inc. 		Villeneuve, Étienne
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-16
Tx date 2016-09-14 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-246,645.176
-101,680 vol
$2.43 each 		50,000
Filed 2016-08-22
Tx date 2016-07-13 		$APO
Acasti Pharma Inc. 		Denis, Ronald
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options 		$-60,000
-5,000 vol
$12.00 each 		0
Filed 2016-08-22
Tx date 2016-07-13 		$APO
Acasti Pharma Inc. 		Fitzgibbon, Pierre
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-90,000
-7,500 vol
$12.00 each 		0
Filed 2016-08-22
Tx date 2016-07-13 		$APO
Acasti Pharma Inc. 		Denis, Ronald
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options 		$-6,250
-2,500 vol
$2.50 each 		5,000
Filed 2016-08-04
Tx date 2016-08-03 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-157.00
-100 vol
$1.57 each 		151,680
Filed 2016-08-03
Tx date 2016-08-02 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-3,206.95
-2,069 vol
$1.55 each 		151,780
Filed 2016-08-01
Tx date 2016-07-28 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-310.00
-200 vol
$1.55 each 		153,849
Filed 2016-07-26
Tx date 2016-07-25 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-477.00
-300 vol
$1.59 each 		154,049
Filed 2016-07-22
Tx date 2016-07-20 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-150.00
-100 vol
$1.50 each 		154,349
Filed 2016-07-19
Tx date 2016-07-14 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-36,617.895
-23,550 vol
$1.55 each
Filed 2016-07-19
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report 		178,000
Filed 2016-07-19
Tx date 2016-07-14 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-36,617.895
-23,550 vol
$1.55 each 		154,450
Filed 2016-07-19
Tx date 2016-07-15 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-1.60
-1 vol
$1.60 each
Filed 2016-07-19
Tx date 2016-07-15 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-1.60
-1 vol
$1.60 each 		154,449
Filed 2016-07-19
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-18
Tx date 2016-07-14 		$APO
Acasti Pharma Inc. 		Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$7,695
+5,000 vol
$1.54 each 		5,000
Filed 2016-07-13
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Canan, Jean-Marie
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-13
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report 		235,906
Filed 2016-07-13
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Neufeld, Victor
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-21
Tx date 2016-06-16 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-105,000
-7,500 vol
$14.00 each 		7,500
Filed 2016-06-21
Tx date 2016-06-16 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-280,000
-20,000 vol
$14.00 each 		70,800
Filed 2016-06-21
Tx date 2016-06-16 		$APO
Acasti Pharma Inc. 		Huart, Benoît
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-70,000
-5,000 vol
$14.00 each 		8,600
Filed 2016-06-21
Tx date 2016-06-16 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Options Groupe 4A
52 - Expiration of options 		$-140,000
-10,000 vol
$14.00 each 		0
Filed 2016-06-01
Tx date 2016-05-30 		$APO
Acasti Pharma Inc. 		Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$41,790
+21,000 vol
$1.99 each 		34,700
Filed 2016-06-01
Tx date 2016-05-30 		$APO
Acasti Pharma Inc. 		Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$398,000
+200,000 vol
$1.99 each 		210,000
Filed 2016-06-01
Tx date 2016-05-30 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$62,486
+31,400 vol
$1.99 each 		90,800
Filed 2016-05-18
Tx date 2016-05-12 		$APO
Acasti Pharma Inc. 		D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-18
Tx date 2016-05-12 		$APO
Acasti Pharma Inc. 		D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$819,000
+525,000 vol
$1.56 each 		525,000
Filed 2016-05-18
Tx date 2016-05-12 		$APO
Acasti Pharma Inc. 		D'Alvise, Janelle
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-01-12
Tx date 2016-01-12 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
11 - Acquisition or disposition carried out privately 		$-8,500
-3,400 vol
$2.50 each 		5,064,694
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+592,500 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+592,500 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+592,500 vol 		592,500
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-533,250 vol
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-533,250 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
10 - Acquisition or disposition in the public market 		$12,500
+10,000 vol
$1.25 each
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
10 - Acquisition or disposition in the public market 		$12,500
+10,000 vol
$1.25 each
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+10,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+10,000 vol 		10,000
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-9,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+10,000 vol 		10,000
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-9,000 vol
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-9,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+10,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+10,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+10,000 vol
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-9,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
10 - Acquisition or disposition in the public market 		$25,000
+20,000 vol
$1.25 each
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+20,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+20,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+20,000 vol 		20,000
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-18,000 vol
Filed 2015-12-09
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-18,000 vol
Filed 2015-12-09
Tx date 2013-12-03 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Units)
15 - Acquisition or disposition under a prospectus
+740,625 vol
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-76,695 vol 		8,522
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-2,250 vol 		250
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-64,800 vol 		7,200
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-65,250 vol 		7,250
Filed 2015-11-03
Tx date 2015-10-25 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-62,500
-25,000 vol
$2.50 each
Filed 2015-11-03
Tx date 2015-10-25 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-62,500
-25,000 vol
$2.50 each
Filed 2015-11-03
Tx date 2015-10-25 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-2,500 vol 		4,700
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-90,000 vol 		10,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-135,000 vol 		15,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Fitzgibbon, Pierre
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-4,500 vol 		500
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Fitzgibbon, Pierre
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-67,500 vol 		7,500
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-123,300 vol 		13,700
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Huart, Benoît
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-12,375 vol 		1,375
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Huart, Benoît
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-122,400 vol 		13,600
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-63,000 vol 		7,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-534,600 vol 		59,400
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-18,000 vol 		2,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-9,000 vol 		1,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Montgomery, Adrian Taylor
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-157,500 vol 		17,500
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Moretz, John Morris
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-720,000 vol 		80,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-45,612,839 vol 		5,068,094
Filed 2015-11-03
Tx date 2011-09-07 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market 		$5,000,000
+4,000,000 vol
$1.25 each
Filed 2015-11-03
Tx date 2011-09-07 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market 		$5,000,000
+4,000,000 vol
$1.25 each 		4,326,196
Filed 2015-11-03
Tx date 2011-09-08 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market 		$1,804,325
+1,443,460 vol
$1.25 each
Filed 2015-11-03
Tx date 2011-09-08 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market 		$1,804,325
+1,443,460 vol
$1.25 each 		5,769,656
Filed 2015-11-03
Tx date 2011-09-09 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market 		$11,537,937
+9,230,350 vol
$1.25 each
Filed 2015-11-03
Tx date 2011-09-09 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
10 - Acquisition or disposition in the public market 		$11,537,937
+9,230,350 vol
$1.25 each 		15,000,006
Filed 2015-11-03
Tx date 2011-09-19 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
57 - Exercise of rights 		$-18,750,007.50
-15,000,006 vol
$1.25 each
Filed 2015-11-03
Tx date 2011-09-19 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Subscription Rights juin 2011
57 - Exercise of rights 		$-18,750,007.50
-15,000,006 vol
$1.25 each 		0
Filed 2015-11-03
Tx date 2010-12-31 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Séries 3)
55 - Expiration of warrants 		$-2,832,647.60
-7,081,619 vol
$0.40 each 		0
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Neptune Technologies & Bioressources inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-533,250 vol 		59,250
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-18,000 vol 		2,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-185,400 vol 		20,600
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Options Groupe 11A
37 - Stock split or consolidation
-67,500 vol 		7,500
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Options Groupe 1A
37 - Stock split or consolidation
-22,500 vol 		2,500
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Options Groupe 4A
37 - Stock split or consolidation
-90,000 vol 		10,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Warrants (Units)
37 - Stock split or consolidation
-9,000 vol 		1,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Tuckson, Reed
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-6,569 vol 		730
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Tuckson, Reed
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-157,500 vol 		17,500
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Turcotte, Mario
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-45,000 vol 		5,000
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-820,080 vol 		91,120
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-450,000 vol 		50,000
Filed 2015-11-03
Tx date 2013-10-08 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Warrants (Séries 4)
55 - Expiration of warrants 		$-82,500
-165,000 vol
$0.50 each 		0
Filed 2015-11-03
Tx date 2015-02-16 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Warrants (Séries 6)
55 - Expiration of warrants 		$-562,500
-375,000 vol
$1.50 each 		0
Filed 2015-11-03
Tx date 2015-02-16 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Warrants (Séries 7)
55 - Expiration of warrants 		$-562,500
-375,000 vol
$1.50 each 		0
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Wenker, Jerald Joseph
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-2,250 vol 		250
Filed 2015-11-03
Tx date 2015-10-15 		$APO
Acasti Pharma Inc. 		Wenker, Jerald Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-157,500 vol 		17,500
Filed 2015-09-30
Tx date 2014-01-24 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
30 - Acquisition or disposition under a purchase/ownership plan
+3,333 vol
Filed 2015-09-30
Tx date 2014-01-24 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-9,533.81
-6,667 vol
$1.43 each 		13,333
Filed 2015-09-30
Tx date 2014-01-24 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-4,766.19
-3,333 vol
$1.43 each
Filed 2015-09-30
Tx date 2014-01-24 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Restricted Share Units
30 - Acquisition or disposition under a purchase/ownership plan
-3,333 vol
Filed 2015-09-30
Tx date 2014-01-24 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$9,533
+6,667 vol
$1.43 each 		59,167
Filed 2015-09-30
Tx date 2014-01-24 		$APO
Acasti Pharma Inc. 		Denis, Ronald
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$4,766
+3,333 vol
$1.43 each
Filed 2015-08-25
Tx date 2015-08-24 		$APO
Acasti Pharma Inc. 		Paradis, Mario
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-25
Tx date 2015-08-24 		$APO
Acasti Pharma Inc. 		Paradis, Mario
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-20
Tx date 2015-08-19 		$APO
Acasti Pharma Inc. 		Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$48,000
+100,000 vol
$0.48 each 		100,000
Filed 2015-08-20
Tx date 2015-08-19 		$APO
Acasti Pharma Inc. 		Wenker, Jerald Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$48,000
+100,000 vol
$0.48 each 		175,000
Filed 2015-08-20
Tx date 2015-08-19 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$48,000
+100,000 vol
$0.48 each 		500,000
Filed 2015-08-20
Tx date 2015-08-19 		$APO
Acasti Pharma Inc. 		Tuckson, Reed
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$48,000
+100,000 vol
$0.48 each 		175,000
Filed 2015-08-20
Tx date 2015-08-19 		$APO
Acasti Pharma Inc. 		Montgomery, Adrian Taylor
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$48,000
+100,000 vol
$0.48 each 		175,000
Filed 2015-08-20
Tx date 2015-07-14 		$APO
Acasti Pharma Inc. 		Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-08-07
Tx date 2014-06-26 		$APO
Acasti Pharma Inc. 		Fitzgibbon, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$90,000
+75,000 vol
$1.20 each 		75,000
Filed 2015-08-07
Tx date 2014-06-26 		$APO
Acasti Pharma Inc. 		Wenker, Jerald Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$45,000
+37,500 vol
$1.20 each 		75,000
Filed 2015-08-07
Tx date 2014-06-26 		$APO
Acasti Pharma Inc. 		Wenker, Jerald Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$45,000
+37,500 vol
$1.20 each
Filed 2015-08-07
Tx date 2014-06-26 		$APO
Acasti Pharma Inc. 		Montgomery, Adrian Taylor
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$90,000
+75,000 vol
$1.20 each 		75,000
Filed 2015-08-07
Tx date 2014-06-26 		$APO
Acasti Pharma Inc. 		Montgomery, Adrian Taylor
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$90,000
+75,000 vol
$1.20 each
Filed 2015-08-07
Tx date 2014-06-26 		$APO
Acasti Pharma Inc. 		Fitzgibbon, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$90,000
+75,000 vol
$1.20 each
Filed 2015-07-23
Tx date 2015-07-14 		$APO
Acasti Pharma Inc. 		Crewe, Katherine
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-21
Tx date 2015-07-14 		$APO
Acasti Pharma Inc. 		Carter, Roderick Noel
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-15
Tx date 2015-07-14 		$APO
Acasti Pharma Inc. 		Roy, François R.
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-15
Tx date 2015-07-14 		$APO
Acasti Pharma Inc. 		Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2015-06-17
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$900.00
+2,500 vol
$0.36 each 		20,000
Filed 2015-06-17
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$4,500
+12,500 vol
$0.36 each 		70,000
Filed 2015-06-17
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Huart, Benoît
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$900.00
+2,500 vol
$0.36 each 		13,750
Filed 2015-06-17
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$900.00
+2,500 vol
$0.36 each 		2,500
Filed 2015-06-17
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$13,500
+37,500 vol
$0.36 each 		911,200
Filed 2015-06-17
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
57 - Exercise of rights 		$2,250
+6,250 vol
$0.36 each 		85,217
Filed 2015-06-16
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Huart, Benoît
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-900.00
-2,500 vol
$0.36 each 		0
Filed 2015-06-16
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Waksal, Harlan
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-13,500
-37,500 vol
$0.36 each 		0
Filed 2015-06-16
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Timperio, Michel
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-2,250
-6,250 vol
$0.36 each 		0
Filed 2015-06-16
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-900.00
-2,500 vol
$0.36 each 		0
Filed 2015-06-16
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-4,500
-12,500 vol
$0.36 each 		0
Filed 2015-06-16
Tx date 2015-06-15 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-900.00
-2,500 vol
$0.36 each 		0
Filed 2015-06-08
Tx date 2015-06-01 		$APO
Acasti Pharma Inc. 		Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$39,150
+87,000 vol
$0.45 each 		137,000
Filed 2015-06-08
Tx date 2015-06-01 		$APO
Acasti Pharma Inc. 		Ripplinger, John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$43,200
+96,000 vol
$0.45 each 		206,000
Filed 2015-06-08
Tx date 2015-06-01 		$APO
Acasti Pharma Inc. 		Lemieux, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$76,050
+169,000 vol
$0.45 each 		594,000
Filed 2015-06-08
Tx date 2015-06-01 		$APO
Acasti Pharma Inc. 		Huart, Benoît
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$11,700
+26,000 vol
$0.45 each 		136,000
Filed 2015-06-08
Tx date 2015-06-01 		$APO
Acasti Pharma Inc. 		Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$21,150
+47,000 vol
$0.45 each 		72,000
Filed 2015-06-02
Tx date 2015-05-25 		$APO
Acasti Pharma Inc. 		Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2015-06-02
Tx date 2015-05-25 		$APO
Acasti Pharma Inc. 		Harvey, Laurent
5 - Senior Officer of Issuer
Direct Ownership
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report